Selected article for: "average time and day average"

Author: Nori, Priya; Madaline, Theresa; Munjal, Iona; Bhar, Shubha; Guo, Yi; Seo, Susan K.; Porrovecchio, Andrea; Gancher, Elizabeth; Nosanchuk, Joshua; Pirofski, Liise-anne; Ostrowsky, Belinda
Title: Developing Interactive Antimicrobial Stewardship and Infection Prevention Curricula for Diverse Learners: A Tailored Approach
  • Document date: 2017_7_20
  • ID: w5ig7mrl_40
    Snippet: were male and 53% female. The most common syndromes reviewed were skin and soft tissue infections, osteomyelitis, pneumonia, urinary tract infections, and bloodstream infections. Thirty-eight percent met sepsis criteria on admission, and 39% were residents of long-term care facilities. A variety of adjustments were recommended in 71.5% of reviewed cases, including dose reduction for diminished creatinine clearance, penicillin allergy clarificatio.....
    Document: were male and 53% female. The most common syndromes reviewed were skin and soft tissue infections, osteomyelitis, pneumonia, urinary tract infections, and bloodstream infections. Thirty-eight percent met sepsis criteria on admission, and 39% were residents of long-term care facilities. A variety of adjustments were recommended in 71.5% of reviewed cases, including dose reduction for diminished creatinine clearance, penicillin allergy clarification, optimization of Gram-negative coverage based on local susceptibility patterns, and facilitation of ID consultation. Uptake of ASP/physician liaison recommendations determined from postprescription audit was 69.5%. As a secondary outcome, we observed a 1-day reduction in average length of hospitalization compared with a similar time frame in 2013 (7.79 days [August 2013-November 2013] vs 6.69 days [August 2014-November 2014]) [19] .

    Search related documents:
    Co phrase search for related documents
    • average length and dose reduction: 1
    • average length and hospitalization average length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • creatinine clearance and dose reduction: 1, 2, 3, 4